TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
RDNT

RadNet Inc

Healthcare · Diagnostics & Research

71.30$ -2.6% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Ratios

Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.

Tick rows to compare them in a chart (up to 4)

Ratios RDNT
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
Valuation
77.4 41.7 35.5 39.0 50.1 9,672.9 – – – 15.7 17.1 19.6 21.6 69.7 247.7 – – – 104.9 73.3 45.7 65.7 69.1 42.3 151.5 100.7 – – 488.9 776.3 158.7 436.0 – 1,887.8 – – – – – –
0.4 0.3 0.3 0.4 0.6 0.5 0.7 0.8 0.8 0.5 0.6 0.7 0.7 0.9 0.5 0.8 0.8 1.0 1.0 1.4 1.2 1.2 0.9 0.7 0.9 0.7 1.0 1.3 1.2 1.5 2.0 2.5 2.9 2.9 2.0 2.2 2.9 2.6 2.0 2.1
9.3 6.2 5.5 6.5 8.4 7.9 8.6 8.3 7.8 4.0 4.5 5.2 5.4 6.8 4.3 5.5 5.1 6.2 6.2 9.1 7.0 7.1 4.2 3.2 3.8 3.2 4.4 3.3 3.1 3.7 3.9 4.9 5.8 5.8 4.1 4.5 5.4 4.9 4.0 4.4
1.1 0.4 1.0 1.1 1.3 1.1 1.4 1.4 1.4 1.2 1.4 1.4 1.4 1.6 1.2 1.4 1.4 1.5 1.7 2.0 1.8 1.8 1.5 1.3 1.4 1.3 1.6 1.7 1.6 1.8 2.3 2.7 3.1 3.1 2.2 2.4 3.1 2.8 2.3 2.4
9.3 2.8 8.0 8.2 9.8 8.7 11.2 11.4 10.8 10.8 10.3 9.3 8.3 8.0 6.3 8.1 7.8 8.2 8.0 9.5 8.1 8.3 7.6 6.3 7.4 6.7 8.9 9.6 9.1 10.5 13.4 17.2 21.1 21.7 17.9 19.7 25.2 18.3 15.4 16.4
– 11.7 9.3 19.6 18.6 9.3 13.9 17.2 12.2 – – – – 34.1 21.7 6.4 6.1 7.1 7.3 22.7 26.3 430.4 – – – – – – – 43.8 91.5 63.6 55.4 117.3 47.4 55.4 109.3 – – –
-9.0% 8.5% 10.8% 5.1% 5.4% 10.8% 7.2% 5.8% 8.2% -5.7% -5.2% -7.1% -6.8% 2.9% 4.6% 15.7% 16.5% 14.1% 13.7% 4.4% 3.8% 0.2% -2.3% 0.0% -0.5% -9.6% -6.3% -4.1% -4.7% 2.3% 1.1% 1.6% 1.8% 0.9% 2.1% 1.8% 0.9% -3.3% -3.5% -1.2%
Margins
11.8% 12.3% 12.6% 13.2% 12.9% 13.0% 12.1% 12.2% 12.5% 11.0% 11.9% 12.1% 12.0% 13.4% 12.0% 8.8% 9.5% 9.9% 11.3% 14.3% 15.0% 14.6% 13.8% 13.5% 11.6% 11.6% 12.0% 12.3% 13.4% 13.7% 13.7% 13.9% 13.9% 13.6% 11.9% 11.6% 11.4% 11.5% 9.4% 9.7%
3.9% 4.4% 4.7% 5.3% 5.1% 5.4% 4.6% 4.7% 5.2% 3.2% 3.8% 4.3% 4.1% 6.1% 4.6% 3.0% 3.6% 3.3% 5.6% 7.2% 7.7% 6.3% 4.7% 4.0% 2.1% 3.2% 3.7% 3.9% 6.1% 6.1% 6.2% 6.6% 5.9% 5.7% 3.7% 3.4% 3.2% 3.7% 3.8% 4.0%
0.5% 0.8% 0.9% 1.0% 1.2% 0.0% -0.7% -0.6% -0.4% 3.3% 3.5% 3.3% 3.0% 1.3% 0.2% -1.3% -1.0% -1.4% 1.0% 2.0% 2.7% 1.9% 1.4% 1.7% 0.6% 0.7% -0.9% -0.8% 0.3% 0.2% 1.3% 0.6% -0.2% 0.2% -1.7% -0.8% -0.6% -0.9% -0.7% -0.9%
-3.5% 2.9% 3.3% 2.1% 3.2% 5.7% 5.3% 4.5% 6.3% -2.9% -3.2% -4.7% -4.4% 2.6% 2.1% 11.8% 12.4% 13.5% 14.2% 6.3% 4.6% 0.3% -2.2% 0.0% -0.4% -7.2% -6.1% -5.3% -5.8% 3.3% 2.2% 4.0% 5.3% 2.5% 4.2% 4.0% 2.6% -8.7% -6.9% -2.6%
Returns
12.1% 14.9% 15.6% 16.6% 16.7% 0.1% -7.6% -6.9% -4.4% 25.4% 26.4% 26.4% 24.9% 9.7% 1.7% -9.0% -6.6% -9.0% 6.0% 12.4% 15.3% 10.8% 6.1% 7.5% 2.5% 3.2% -4.1% -2.2% 0.6% 0.5% 2.4% 1.1% -0.5% 0.3% -3.6% -1.6% -1.2% -1.7% -1.3% -1.9%
0.5% 0.9% 0.9% 1.1% 1.3% 0.0% -0.7% -0.7% -0.5% 2.9% 2.3% 2.2% 2.1% 0.9% 0.1% -0.8% -0.6% -0.8% 0.6% 1.2% 1.7% 1.2% 0.9% 1.0% 0.3% 0.4% -0.6% -0.5% 0.1% 0.1% 0.7% 0.3% -0.1% 0.1% -1.0% -0.4% -0.3% -0.5% -0.4% -0.5%
Balance Sheet & Debt
650 11 629 618 611 559 568 578 556 661 793 821 811 781 811 729 718 619 756 762 747 686 811 784 785 782 895 567 582 543 366 344 329 333 351 389 352 385 698 676
6.1 0.1 5.5 5.1 5.2 4.7 5.1 5.0 4.7 6.1 5.8 5.1 4.4 3.5 3.8 3.9 3.7 3.1 3.2 2.8 2.6 2.5 3.0 2.8 2.9 2.8 3.4 2.1 2.1 2.0 1.3 1.3 1.3 1.3 1.5 1.7 1.5 1.2 2.2 2.0
4.4% 5.7% 5.8% 6.7% 7.8% 7.1% 8.6% 9.6% 10.4% 11.5% 8.9% 8.4% 8.3% 9.2% 7.3% 8.6% 9.2% 9.3% 10.1% 9.7% 11.0% 11.1% 14.0% 13.9% 13.9% 13.7% 13.6% 21.9% 23.0% 23.4% 29.4% 27.3% 27.3% 27.5% 26.9% 26.5% 28.9% 29.0% 27.8% 25.9%
17.7 0.6 12.8 11.1 9.4 9.9 7.6 6.8 6.2 5.3 5.9 6.4 6.3 5.4 7.3 5.5 5.1 4.4 4.3 4.6 4.0 3.6 3.0 2.8 2.8 2.7 3.0 1.6 1.5 1.4 1.0 1.2 1.2 1.2 1.2 1.3 1.1 1.1 1.1 1.3
Per Share
0.10 0.16 0.17 0.20 0.23 0.00 -0.13 -0.12 -0.09 0.65 0.72 0.70 0.67 0.29 0.04 -0.26 -0.20 -0.28 0.21 0.46 0.64 0.46 0.32 0.41 0.13 0.19 -0.23 -0.21 0.06 0.04 0.31 0.14 -0.06 0.04 -0.43 -0.20 -0.17 -0.25 -0.18 -0.27
18.89 19.07 19.27 19.25 19.16 19.26 19.33 19.35 19.61 19.68 20.49 21.14 22.05 22.79 23.15 21.03 20.49 20.52 20.93 23.51 23.97 24.37 23.80 23.91 23.93 25.07 25.63 25.09 22.96 23.81 23.92 23.34 23.59 24.22 25.13 25.76 26.37 27.13 27.83 28.82
0.79 1.05 1.07 1.21 1.38 1.29 1.67 1.80 1.94 2.57 2.74 2.67 2.67 3.00 2.45 2.92 3.03 3.17 3.49 3.71 4.18 4.24 5.30 5.48 5.43 5.84 5.68 9.74 8.99 9.29 12.60 12.00 11.91 11.95 12.07 12.59 14.17 14.50 14.02 13.92
-0.66 0.56 0.64 0.40 0.62 1.09 1.03 0.87 1.24 -0.58 -0.65 -0.98 -0.98 0.60 0.48 2.49 2.54 2.77 2.98 1.48 1.11 0.07 -0.52 0.00 -0.10 -1.81 -1.57 -1.33 -1.34 0.79 0.53 0.93 1.25 0.60 1.05 1.03 0.70 -2.37 -1.93 -0.74

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?